Anti-CREB (phospho S133) antibody [E113]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
4
(14 Reviews)
|
(296 Publications)
Anti-CREB (phospho S133) antibody [E113] (ab32096) is a rabbit monoclonal antibody detecting CREB in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF, Dot Blot. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 230 publications
- Trusted since 2006
View Alternative Names
Cyclic AMP-responsive element-binding protein 1, CREB-1, cAMP-responsive element-binding protein 1, CREB1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human thyroid carcinoma tissue labelling CREB with purified ab32096 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a goat anti-rabbit IgG H&L (HRP) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Intracellular Flow Cytometry analysis of A431 (human epidermoid carcinoma) cells labeling CREB with purified ab32096 at 1/70 dilution (10μg/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- FuncS
Lab
Functional Studies - Anti-CREB (phospho S133) antibody [E113] (AB32096)
SK-N-SH cells were incubated at 37°C for 30 minutes with vehicle control (0 μM) and different concentrations of (S)-3,5-DHPG (ab120007). Increased expression of CREB (phospho S133) in SK-N-SH cells correlates with an increase in (S)-3,5-DHPGconcentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with unpurified ab32096 at 1/500 dilution and ab32515 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
- FuncS
Lab
Functional Studies - Anti-CREB (phospho S133) antibody [E113] (AB32096)
SK-N-SH cells were incubated at 37°C for 30 minutes with vehicle control (0 μM) and different concentrations of (R,S)-CHPG (ab120039). Increased expression of CREB (phospho S133) in SK-N-SH cells correlates with an increase in (R,S)-CHPG concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with unpurified ab32096 at 1/500 dilution and ab32515 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemical analysis of paraffin-embedded Human astrocytoma tissue labeling CREB with ab32096 at 1/2000 followed by a ready to use ab209101. Nuclear staining on human astrocytoma without alkaline phosphatase treatment (image A). No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab32096 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use ab209101. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunocytochemistry/Immunofluorescence analysis of A431 cells labelling CREB with unpurified ab32096 at 1/250.
Panel A : Cells are untreated.
Panel B : Cells are treated with Phosphatase.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human thyroid gland adenocarcinoma tissue labelling CREB with unpurified ab32096 at 1/250 dilution.
Panel A : Cells are untreated.
Panel B : Cells are treated with Phosphatase.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunocytochemistry/Immunofluorescence analysis of LP treated and untreated HeLa (Human epithelial cell line from cervix adenocarcinoma) labelling CREB with purified ab32096 at 1/200. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain at a dilution of 1/200.
Confocal image showing nuclear staining on HeLa cells .The signal decreased after Lambda Protein Phosphatase treatment ( 31℃,2h).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunocytochemistry/Immunofluorescence analysis of A431(human epidermoid carcinoma) cells +/- AP 37℃ 1h labelling CREB with purified ab32096 at 1/100. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.
Control 1 : primary antibody (1/100) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).
Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).
- IP
Unknown
Immunoprecipitation - Anti-CREB (phospho S133) antibody [E113] (AB32096)
ab32096 (purified) at 1/50 immunoprecipitating CREB (phospho S133) in HeLa whole cell lysate. 10 ug of cell lysate was present in the input. For western blotting, a HRP-conjugated Veriblot for IP Detection Reagent (ab131366) (1/1,500) was used for detection. A rabbit monoclonal IgG (ab172730) was used intead of ab128913 as a negative control (Lane 3).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-CREB (phospho S133) antibody [E113] (ab32096)
Predicted band size: 36 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-CREB (phospho S133) antibody [E113] (AB32096)
ab32096 at 1/100 dilution immunoprecipitating CREB (phospho S133) in HeLa (human cervix adenocarcinoma) treated with 25ug/mL anisomycin for 30 minutes, whole cell lysate, observed at 40 kDa (lanes 1 and 2).
Lane 1 (input) : HeLa treated with 25ug/mL anisomycin for 30 minutes. Whole cell lysate, 10μg.
Lane 2 (+) : ab32096 + HeLa treated with 25ug/mL anisomycin for 30 minutes. Whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32096 in treated with 25ug/mL anisomycin for 30 minutes. Whole cell lysate
For western blotting, ab32096 at 1/200 dilution followed by ab131366 VeriBlot for IP Detection Reagent (HRP) at 1/1000 for detection.
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CREB (phospho S133) antibody [E113] (ab32096)
Predicted band size: 36 kDa
false
Exposure time: 5s
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling CREB with ab32096 at 1/2000 followed by a ready to use ab209101. Nuclear staining on mouse cerebrum without alkaline phosphatase treatment (image A). No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab32096 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use ab209101. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemical analysis of paraffin-embedded Rat cerebrum tissue labeling CREB with ab32096 at 1/2000 followed by a ready to use ab209101. Nuclear staining on rat cerebrum without alkaline phosphatase treatment (image A). No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab32096 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use ab209101. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- IHC-P
AbReview21176****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat hippocampus tissue labelling CREB with unpurified ab32096 at 1/100 dilution. Sections were subjected to antigen retrieval by autoclave prior to blocking with 8% milk for 30 minutes at 37°C. The primary antibody was diluted 1/100 with DAKO antibody diluent and incubated with the sample for 18 hours at 4°C. An LSAB-labeled Streptavidin-Biotin conjugated Goat polyclonal antibody was used undiluted as the secondary antibody.
This image is courtesy of an Abreview submitted by Akiko Shingo.
- WB
Lab
Western blot - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Blocking and diluting buffer : 5% NFDM/TBST
This antibody can't detect signal in mouse and rat brain related tissues.
All lanes:
Western blot - Anti-CREB (phospho S133) antibody [E113] (ab32096) at 1/200 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with 250ng/ml anisomycin for 30 minutes whole cell lysates at 15 µg
Lane 2:
Mouse brain lysates at 15 µg
Lane 3:
Rat brain lysates at 15 µg
Lane 4:
Rat cerebellum lysate at 15 µg
Lane 5:
Mouse hippocampus lysate at 15 µg
Lane 6:
Rat hippocampus lysate at 15 µg
Lane 7:
Rat cerebral cortex lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 36 kDa
false
Exposure time: 3s
- WB
Unknown
Western blot - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-CREB (phospho S133) antibody [E113] (ab32096) at 1/5000 dilution
Lane 1:
Untreated HeLa cell lysate at 10 µg
Lane 2:
HeLa treated with Calyculin A cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 36 kDa
false
- WB
Lab
Western blot - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-CREB (phospho S133) antibody [E113] (ab32096) at 1/5000 dilution
Lane 1:
Untreated C6 cell lysate at 10 µg
Lane 2:
C6 treated with Calyculin A cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 36 kDa
false
- WB
Lab
Western blot - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-CREB (phospho S133) antibody [E113] (ab32096) at 1/5000 dilution
Lane 1:
Untreated NIH/3T3 cell lysate at 10 µg
Lane 2:
NIH/3T3 treated with Calyculin A at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 36 kDa
false
- Dot
Supplier Data
Dot Blot - Anti-CREB (phospho S133) antibody [E113] (AB32096)
Dot blot analysis of CREB (pS133) phospho peptide (Lane 1) and CREB non-phospho peptide (Lane 2) using ab32096 at 1/1000 dilution followed by Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100000 dilution.
Blocking and Diluting buffer and concentration : 5% NFDM /TBST.
Exposure time : 3 minutes.
Related conjugates and formulations (2)
-
Anti-CREB (phospho S133) antibody [E113] - BSA and Azide free
-
HRP Anti-CREB (phospho S133) antibody [E113]
Reactivity data
Product details
Product Specifications
Anti-CREB (phospho S133) antibody [E113] (ab32096) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP, WB in human, mouse, rat samples.
Anti-CREB (phospho S133) antibody [E113] (ab32096) specifically detects CREB Phospho-S133 (UniProt ID: P16220; Molecular weight: 35kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-CREB (phospho S133) antibody [E113] (ab32096) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-CREB (phospho S133) antibody [E113] (ab32096) has been cited over 230 times in peer reviewed journals and is trusted by the scientific community.
Anti-CREB (phospho S133) antibody [E113] (ab32096) has 13 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone E113 - ab220798.
Antibody clone E113 is also available pre-conjugated to a variety of labels for your convenience - HRP (ab219741).
Target Information
CREB (phospho S133) is a transcription factor that plays a vital role in regulating gene expression upon phosphorylation at serine 133. This phosphorylation enhances CREB's ability to activate genes involved in cell survival, metabolism, and proliferation. Dysregulation of CREB phosphorylation at S133 is implicated in several conditions, including cancer, where it aids in tumor development and resistance to apoptosis, and neurodegenerative disorders such as Alzheimer's disease, where it influences neuronal resilience and cognitive function.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CREB contributes significantly to cellular processes such as proliferation differentiation and survival through transcriptional regulation. CREB does not function alone; it frequently associates with other proteins forming complexes to exert its regulatory roles. Additionally CREB influences the development of memory and learning in neurons highlighting its extensive involvement in neurophysiological processes.
Pathways
CREB plays a substantial role in the cAMP signaling pathway as well as the mitogen-activated protein kinase (MAPK) pathway. Through its interaction with kinases and other signaling proteins CREB influences numerous downstream targets affecting cellular responses to external stimuli. Notably protein kinase A (PKA) activates CREB by phosphorylation facilitating its role in various signal transduction pathways and linking it to downstream transcriptional events.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (296)
Recent publications for all applications. Explore the full list and refine your search
The Tohoku journal of experimental medicine : PubMed41034038
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1588105 PubMed40693273
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 16:1570685 PubMed40687591
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1573705 PubMed40641602
2025
Applications
Unspecified application
Species
Unspecified reactive species
Food science & nutrition 13:e70408 PubMed40491976
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1592187 PubMed40453656
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2053 PubMed40021651
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 19:911-929 PubMed39959122
2025
Applications
Unspecified application
Species
Unspecified reactive species
Life (Basel, Switzerland) 14: PubMed39768379
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39684198
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com